MUC1 and cancer: In comparison with both of the controls (CTL and Isotype IgG treated), the levels of cholesterol uptake were significantly reduced by the anti-MUC1 antibody within three cancer cell lines and less reduced in normal HUVEC cells (Figure 3C).